ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Intercept Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Intercept Pharmaceuticals, INC. (Intercept Pharma 401(k) Plan · EIN 22-3868459 · PN 001): $50.68M net assets, 250 active participants, and $33.93 per $10,000 (33.93 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorIntercept Pharmaceuticals, INC.
Filing IdentifierIntercept Pharma 401(k) Plan · EIN 22-3868459 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$50.68M
Active Participants250
Direct Admin Fee Rate$33.93 per $10,000 (33.93 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderBank of America / Merrill
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI